Angioplasty Triggers Intracoronary Leukotrienes and Lipoxin A4. Impact of Aspirin Therapy

Circulation - United States
doi 10.1161/01.cir.86.1.56
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Aspirin Triggers Antiinflammatory 15-Epi-Lipoxin A4 and Inhibits Thromboxane in a Randomized Human Trial

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2004English

Leukotrienes and Aspirin Induced Asthma.

Thorax
PulmonaryRespiratory Medicine
1993English

Aspirin-Triggered Lipoxin A4 (15-Epi-Lxa4) Increases the Endothelial Viability of Human Corneas Storage in Optisol-Gs

Journal of Ocular Pharmacology and Therapeutics
OphthalmologyPharmacology
2011English

The Association Between Serum Lipoxin A4 Level and Lupus Nephritis

The Medical Journal of Cairo University
2019English

Aspirin-Triggered Lipoxin in Patients Treated With Aspirin and selectivevs.nonselective COX-2 Inhibitors

British Journal of Clinical Pharmacology
Pharmacology
2010English

Lipoxin A4 Activates ALX/FPR2 Receptor to Regulate Conjunctival Goblet Cell Secretion

Mucosal Immunology
AllergyImmunology
2016English

Lipoxin A4 Inhibits UV Radiation-Induced Skin Inflammation and Oxidative Stress in Mice

Journal of Dermatological Science
DermatologyBiochemistryMolecular Biology
2018English

Anti-Inflammatory Lipoxin A4 Is an Endogenous Allosteric Enhancer of CB1 Cannabinoid Receptor

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

Lipoxin A4 Is an Allosteric Endocannabinoid That Strengthens Anandamide-Induced CB1 Receptor Activation

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy